Brookwood Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Buy
1,219
+34
+3% +$11.6K 0.05% 328
2026
Q1
$417K Sell
1,185
-199
-14% -$70.9K 0.05% 322
2025
Q4
$453K Sell
1,384
-65
-4% -$20.6K 0.05% 310
2025
Q3
$409K Buy
1,449
+447
+45% +$130K 0.05% 310
2025
Q2
$280K Sell
1,002
-296
-23% -$83.9K 0.05% 346
2025
Q1
$404K Buy
+1,298
New +$383K 0.07% 254

Other funds holding AMGN

Brookwood Investment Group's AMGN Position: Q2 2026 in Review

Brookwood Investment Group increased its Amgen (AMGN) stake by 2.9% in Q2 2026, buying an estimated $11.6K and bringing the position to 1,219 shares worth $441K. The position accounts for 0.05% of the portfolio, ranked #328.

Brookwood Investment Group first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $453K in Q4 2025. 1,456 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brookwood Investment Group held 1,219 shares of Amgen worth $441K as of Q2 2026.
  • Brookwood Investment Group bought 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 0.05% of Brookwood Investment Group's portfolio in Q2 2026, its #328 holding.
  • Brookwood Investment Group first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Brookwood Investment Group's Amgen position peaked at $453K in Q4 2025.
  • 1,456 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.